Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-01-10 @ 3:19 PM
Study NCT ID:
NCT03387020
Status:
COMPLETED
Last Update Posted:
2021-08-27
First Post:
2017-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Sponsor:
Pediatric Brain Tumor Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-05
First Submit QC Date:
None
Study First Post Date:
2017-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-09
Results First Submit QC Date:
None
Results First Post Date:
2021-08-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-02
Last Update Post Date:
2021-08-27
Last Update Post Date Type:
ACTUAL